Published in Health Risk Factor Week, January 3rd, 2006
More and more, plasma exchange is being endorsed by a number of health-related associations as useful for preventing acute renal failure at the onset of multiple myeloma. However, a recent study at 14 medical centers across Canada found no conclusive evidence to suggest that this treatment provides any kind of benefit to patients.
"In what we believe to be the largest randomized, controlled trial conducted to date, we found no conclusive evidence that plasma exchange provides a substantial benefit in reducing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.